Showing 5,804 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

GSK's two-drug HIV treatment meets main goal in late stage studies

Editor's pick
Reuters
15 June 2018
How HIV works

ART Simplification Does Not Affect Systemic Inflammation in Virologically Suppressed HIV

Editor's pick
Infectious Disease Advisor
15 June 2018
Adherence

'Emotional closeness’ key to successful HIV treatment support

Editor's pick
AVERT
15 June 2018
New & experimental HIV treatments

ViiV Healthcare reports positive results for landmark phase III studies for dolutegravir and lamivudine

Editor's pick
ViiV Healthcare press release
15 June 2018
Access to healthcare

Russia’s HIV/AIDS epidemic is getting worse, not better

Editor's pick
Science
12 June 2018
New & experimental HIV treatments

Single Shot of PRO 140 mAb Cuts HIV Load in Two Thirds on Failing ART

Editor's pick
National AIDS Treatment Advocacy Project
11 June 2018
Drug interactions & pharmacokinetics

Closer Monitoring Recommended for Older Patients Treated With Dolutegravir for HIV

Editor's pick
Infectious Disease Advisor
11 June 2018
Treatment for women

FDA says Prezcobix should not be given to pregnant women

Editor's pick
Healio (requires free registration)
11 June 2018
CD4 count

Low CD4 count in patients with HIV prolongs influenza viral shedding

Editor's pick
Healio itj+ (requires free registration)
11 June 2018
Cardiovascular disease

Cumulative Ritonavir-Boosted Darunavir Use May Be Associated With Increased CVD Risk

Editor's pick
Infectious Disease Advisor
11 June 2018
New & experimental HIV treatments

Is the World Ready for Long-Acting HIV Treatment?

Editor's pick
The Body Pro
11 June 2018
Treatment outcomes & life expectancy

Navigating Mixed Messages About HIV

Editor's pick
Poz
8 June 2018
New & experimental HIV treatments

China approves Albuviritide: first domestically developed, long-acting injectable anti-HIV drug

Editor's pick
Firstpost
6 June 2018
Starting treatment

Starting HIV treatment at diagnosis slashes drop out, drug failure rates, China study finds

Editor's pick
Science Speaks
4 June 2018
Access to healthcare

Continuous Medicaid Coverage Essential for People Living With HIV

Editor's pick
Infectious Disease Advisor
1 June 2018
Side effects

Integrase Inhibitors Are Well Tolerated

Editor's pick
Poz
31 May 2018
Drug interactions & pharmacokinetics

Potential interactions between ART and other medications present in over half of older HIV-positive people

News
31 May 2018
Treatment guidelines

South Africa: Birth defects fears prompt warnings about new ARV

Editor's pick
Health-e
29 May 2018
PrEP

Differing drug distribution in penis and rectum of men taking TDF/FTC PrEP

Editor's pick
NATAP
25 May 2018
Adherence

Short Cycle ART Noninferior to Continuous Therapy in Youth With HIV

Editor's pick
Infectious Disease Advisor
25 May 2018
Treatment for women

BHIVA statement on Potential Safety Signal in Infants Born to Women Conceiving on Dolutegravir

Editor's pick
British HIV Association
23 May 2018
Cardiovascular disease

What's the connection between HIV and high blood pressure?

Editor's pick
American Heart Association News
23 May 2018
Treatment for women

Dolutegravir may cause birth defects, European Medicines Agency warns

News
21 May 2018
Pharmaceutical industry

AIDS Healthcare Foundation files two lawsuits against Gilead

Editor's pick
The Bay Area Reporter
21 May 2018